Teradyne Inc

TER: XNAS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
LOCK|X!LOCK|Hk&LOCK|lm>gmb

Teradyne Earnings: A Positive Outlook for 2025 and Beyond Matches Our Long-Term Recovery Thesis

Teradyne's fourth-quarter sales rose 12% year over year and 2% sequentially to $753 million. Management guided to mid-teens revenue growth in the first quarter and 2025 and provided a new long-term model including a midpoint target of 15% revenue growth through 2028.

Sponsor Center